title: Kawasaki disease.
authors.affiliation: Department of Primary Care Health Sciences, University of Oxford, Oxford, UK anthony.harnden@phc.ox.ac.uk.
authors.forename: Anthony
authors.initials: A
authors.lastname: Harnden
authors.affiliation: University Hospitals Bristol NHS Foundation Trust, University of Bristol, Bristol, UK.
authors.forename: Robert
authors.initials: R
authors.lastname: Tulloh
authors.affiliation: Murdoch Childrens Research Institute and Department of Paediatrics, University of Melbourne, Parkville, VIC, Australia.
authors.forename: David
authors.initials: D
authors.lastname: Burgner
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D002675:Child, Preschool; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use; D008297:Male; D009080:Mucocutaneous Lymph Node Syndrome / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D001241:Aspirin